Frias, J.P., Deenadayalan, S., Erichsen, L., Knop, F.K., Lingvay, I., Macura, S., Mathieu, C., Pedersen, S.D., & Davies, M.J
Vutiglabridin mitigates the weight-loss plateau under calorie-restriction conditions To evaluate its anti-obesity efficacy, DIO mice were treated for 3 weeks with 50 mg/kg Vutiglabridin, a dose effective in a previous study [24]
Medical weight loss with GLP-1 medications requires regular monitoring and support
In elaboration of these observations, work in an alpha-cell-specific PC1/3 knockout mouse model demonstrates that the loss of alpha-cell GLP-1 production impairs glucose homeostasis and GSIS in metabolically stressed mice but not in chow-fed mice (19)
How and when should I stop my GLP-1 before bariatric surgery
[DOI] [PubMed] [Google Scholar] 30.Chen G.L., Xu Y.B., Wu J.L., Li N., Guo M.Q